bufalin and pd 98059

bufalin has been researched along with pd 98059 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dong, Q; Hou, K; Li, D; Liu, Y; Qu, X; Teng, Y; Zhang, J; Zhang, Y1
Gao, Y; Li, E; Liu, X; Liu, Y; Sun, H; Wang, Q; Wang, Y; Wang, Z; Zhu, Z1
Ding, Y; Liu, XJ; Liu, YP; Wang, XL; Yang, HC; Yue, M1

Other Studies

3 other study(ies) available for bufalin and pd 98059

ArticleYear
PI3K/Akt is involved in bufalin-induced apoptosis in gastric cancer cells.
    Anti-cancer drugs, 2009, Volume: 20, Issue:1

    Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Bufanolides; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chromones; Dose-Response Relationship, Drug; Flavonoids; Humans; Morpholines; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-cbl; Signal Transduction; Stomach Neoplasms; Time Factors

2009
Bufalin induces the apoptosis of acute promyelocytic leukemia cells via the downregulation of survivin expression.
    Acta haematologica, 2012, Volume: 128, Issue:3

    Topics: Apoptosis; Bufanolides; Caspase 3; Cell Proliferation; Down-Regulation; Enzyme Activation; Flavonoids; Humans; Inhibitor of Apoptosis Proteins; Leukemia, Promyelocytic, Acute; Neoplastic Cells, Circulating; Survivin

2012
[Effect of bufalin on proliferation and apoptosis through ERK/RSK2 pathway in human esophageal carcinoma cell line xenografts in nude mice].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2016, May-23, Volume: 38, Issue:5

    Topics: Animals; Antineoplastic Agents; Apoptosis; Bufanolides; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Flavonoids; Heterografts; Humans; MAP Kinase Signaling System; Mice; Mice, Nude; Necrosis; Neoplasm Transplantation; Protein Kinase Inhibitors; RNA, Messenger; Transplantation, Heterologous; Tumor Burden

2016